A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)

• Status: NOT_YET_RECRUITING
• Trial end date: 2040-01-01

Summary

Magnetic resonance imaging (MRI) is commonly used in healthcare, and sometimes it shows small areas of brain damage called Covert Brain Infarcts (CBIs). These are usually found by chance when people have scans for things like headaches or dizziness. Although CBIs don't cause symptoms at the time, they are linked to a higher risk of future stroke and death.

There is currently no standard treatment for CBIs, and doctors have different approaches-some give stroke-preventing medication (like antiplatelets or statins), while others don't treat at all. This is mostly because there isn't enough research yet.

This study will test whether stroke-preventing treatments help people with CBIs. It will also look at whether having a CBI increases the risk of dementia, and whether treatment might lower that risk.

• Phase: PHASE3

Details

• Lead Sponsor: Aarhus University Hospital
• Collaborators: Aalborg University Hospital; Bispebjerg Hospital; Gdstrup Hospital; Herlev Hospital; Insel Gruppe AG, University Hospital Bern; Lund University Hospital; Odense University Hospital; Oslo University Hospital; Rigshospitalet, Denmark; University Medical Center Hamburg-Eppendorf (UKE); Zealand University Hospital
• Treatments: Aspirin; Atorvastatin; Clopidogrel; Rosuvastatin Calcium